Drug Trial Radar · NCT06196879
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
479
Actual
Start
Feb 27, 2024
Primary completion
Dec 16, 2025
Study completion Mar 19, 2026
Sponsor
- Lead sponsor
- Upstream Bio Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will evaluate the incidence of asthma exacerbations, other pharmacodynamic (PD) parameters such as lung function and asthma control, and the safety and tolerability of verekitug (UPB-101) compared to placebo.
Conditions
- Severe Asthma
Interventions
Verekitug (UPB-101)Drug
Verekitug (UPB-101) formulated solution
PlaceboDrug
Verekitug (UPB-101) matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annual Asthma Exacerbation Rate (AAER)Time frame: Baseline up to Week 60
Locations
155 sites in 15 countries. Site status is shown where the registry gives one.
AllerVie Clinical Research
Birmingham, Alabama
Kern Research, Inc.
Bakersfield, California
Velocity Clinical Research - Lafayette LA
Los Angeles, California
Newport Native MD Inc
Newport Beach, California
California Medical Research Associates Inc.
Northridge, California
Integrated Research of Inland Inc
Upland, California
Allergy & Asthma Clinical Research
Walnut Creek, California
Allianz Research Institute
Westminster, California
Woodland Clinic Medical Group
Woodland, California
National Jewish Health
Denver, Colorado
Advance Pharma Research
Cutler Bay, Florida
Unique Clinical Trials
Doral, Florida
Health and Life Research Institute, LLC
Miami, Florida
Phoenix Medical Research
Miami, Florida
Research Institute of South Florida
Miami, Florida
Nouvelle Clinical Research
Miami, Florida
Anderson Allergy And Asthma, PA
Orlando, Florida
Edward Jenner Research Group, LLC
Plantation, Florida
R&B Medical Center
Tampa, Florida
Clinical Site Partners dba Flourish research
Winter Park, Florida
Clinical Site Partners, LLC dba Flourish Research
Winter Park, Florida
Pivotal Research Solutions
Stonecrest, Georgia
RNA America Health Sciences
Sugar Hill, Georgia
Treasure Valley Medical Research
Boise, Idaho
Velocity Clinical Research - Meridian
Meridian, Idaho
Howard County Center for Lung and Sleep Medicine LLC
Columbia, Maryland
Chesapeake Clinical Research Inc
White Marsh, Maryland
Exordia Medical Research Inc
Fall River, Massachusetts
Pulmonary Research Institute of Southeast Michigan
Farmington Hills, Michigan
AA Medical Research Center
Flint, Michigan
Mayo Clinic
Rochester, Minnesota
M3 Wake Research
Las Vegas, Nevada
Urban Health Plan INC
The Bronx, New York
Advanced Respiratory and Sleep Medicine LLC
Huntersville, North Carolina
Summit Research Group LLC
Munroe Falls, Ohio
Toledo Institute of Clinical Research Inc
Toledo, Ohio
OK Clinical Research, LLC
Edmond, Oklahoma
Portland Clinical Research
Clackamas, Oregon
Velocity Clinical Research - Medford
Medford, Oregon
Velocity Clinical Research - Anderson
Anderson, South Carolina
Showing 40 of 155 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.